As reported on (b)(6) 2014, a (b)(6) female patient presented for a lecd thermal ablation of the liver.During the ablation, it was noted the patient developed arterial fibrillation.The treating physician determined to continue with the procedure.There was no report of permanent harm or injury to the patient due to the event.The nanoknife system was reported as available for return to the manufacturer for evaluation.
|
It was reported that the device involved in the incident is available to be returned to the manufacturer for evaluation.To date the device has yet to be returned.Attempts are being made to obtain the device.An investigation into the root cause for incident is currently in progress.The results of the investigation will be sent via a follow up medwatch.A review of the device history records was performed for the serial number (b)(4).A review of the device history records for the sulis accusync (serial number (b)(4)) noted no repairs, servicing and/or upgrades since the unit was manufactured.The review confirms that the unit met all material, assembly, and performance specifications.(b)(4).
|